Can I read Management of cutaneous side effects of inflammatory bowel disease therapy: A dermatologic viewpoint on EtoBox?

Management of cutaneous side effects of inflammatory bowel disease therapy: A dermatologic viewpoint by Justin Lee; Noelle Lemons; Alyssa Lorenze; Tarika Sejal Chowdhary; Zachary Zinn; Swapna Gayam is a Medicine article available to read on EtoBox.

What is Management of cutaneous side effects of inflammatory bowel disease therapy: A dermatologic viewpoint about?

## Abstract Medications used in the treatment of inflammatory bowel disease cause a wide range of dermatologic side effects, and minimal guidance exists on how to manage them. The intention of this review article is to summarize common dermatologic adverse reactions related to inflammatory bowel disease therapy and to provide evidence‐based guidance on management. We conducted a scoping review using PubMed and Google Scholar to identify studies reporting clinical information on dermatologic side effects of medications used in the treatment of inflammatory bowel disease. The most commonly reported dermatological adverse effects from inflammatory bowel disease therapy were cutaneous malignancy and cutaneous infections. Thiopurines, methotrexate, tumor necrosis factor (TNF) inhibitors, interleukin (IL)‐12/23 inhibitors, and integrin inhibitors can be continued if nonmelanoma skin cancer arises during therapy and the malignancy should be surgically excised. TNF inhibitors and IL‐12/23 inhibitors can be continued in the setting of stage I surgically resectable melanoma but should be discontinued in advanced melanoma. For complicated cutaneous bacterial infections, methotrexate and TNF i

Who reads Management of cutaneous side effects of inflammatory bowel disease therapy: A dermatologic viewpoint?

Author

Justin Lee; Noelle Lemons; Alyssa Lorenze; Tarika Sejal Chowdhary; Zachary Zinn; Swapna Gayam

Publisher

Wiley

Published

2021

Language

EN

Field

Medicine (Health Sciences)